Evidence map›Paper›PMID 39895742›Full record

ArticleACS omega2025

Comprehensive Physicochemical Characterization and in Vitro Human Cell Culture Studies of an Innovative Biocompatible and Biodegradable Silk-Derived Protein Hydrolysate, SDP-4.

Hasham Shafi, Andrea J Lora, Saurabh Aggarwal, David W Infanger, Brian D Lawrence, Heidi M Mansour

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hasham ShafiFlorida International University Center for Translational Science, Port St. Lucie, Florida 34987, United States.
Andrea J LoraFlorida International University Center for Translational Science, Port St. Lucie, Florida 34987, United States.
Saurabh AggarwalHerbert Wertheim College of Medicine, Department of Cellular & Molecular Medicine, Florida International University, Miami, Florida 33199, United States.
David W InfangerSilk Technologies, Ltd., Maple Grove, Minnesota 55369, United States.
Brian D LawrenceSilk Technologies, Ltd., Maple Grove, Minnesota 55369, United States.
Heidi M MansourFlorida International University Center for Translational Science, Port St. Lucie, Florida 34987, United States.ORCID https://orcid.org/0000-0003-3993-9210

Funding

Chronic Widespread Pain in HIV: Novel Mechanisms and TherapeuticsR01DA049657 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGGARWAL, SAURABH · 2021 to 2025
$1.8M
Identification of AMD3100 (Plerixafor) as a potential lead compound for chlorine toxicityU01ES033265 · NIEHS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGGARWAL, SAURABH · 2021 to 2023
$1.3M
NIDA NIH HHS R01 DA049657NIEHS NIH HHS U01 ES033265
6 · The paper itself

Abstract

SDP-4 is a soluble silk fibroin-derived protein hydrolysate extracted from the

Identifiers

PMID39895742
PMCPMC11780451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.